Loading clinical trials...
Loading clinical trials...
To Investigate the Effect of Esketamine on Hemodynamics and Postoperative Pulmonary Complications in Patients Undergoing Heart Valve Replacement Surgery
Conditions
Interventions
Esketamine hydrochloride injection
Locations
1
China
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
Start Date
January 1, 2024
Primary Completion Date
May 1, 2025
Completion Date
May 1, 2025
Last Updated
June 21, 2024
NCT06400004
NCT06788275
NCT05208567
NCT06590467
NCT06535568
NCT06769880
Lead Sponsor
Zhang XIao Mei
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions